Credo Life Science
Posted on 27th January 2022
How to Choose the Best Itraconazole Granules Manufacturer
Itraconazole is a widely used broad-spectrum antifungal, but its poor water solubility makes it a genuinely challenging molecule to formulate. Choosing the right granule manufacturer can make the difference between a stable, bioequivalent product and a formulation that underperforms.
Why Itraconazole Formulation Is Difficult
Classified as a BCS Class II drug, itraconazole has low water solubility and pH-dependent absorption. Effective formulations typically rely on techniques such as layering the drug onto sugar or cellulose cores combined with functional polymer coatings to improve dissolution and bioavailability.
Key Manufacturing Capabilities to Look For
A strong itraconazole granules manufacturer should offer IR, SR, and EC granule technology platforms, proven experience formulating poorly water-soluble actives, and rigorous analytical testing including dissolution profiling across multiple pH conditions to confirm consistent absorption.
Regulatory Credentials That Matter
Look for WHO-GMP certification and, ideally, DMF filings covering your target regulatory markets. A manufacturer with documented experience navigating complex solubility-related formulation challenges brings genuine value beyond standard granulation capability.
Questions to Ask Before Committing
Ask potential partners how they approach solubility enhancement, what analytical methods they use to confirm dissolution consistency batch to batch, and whether they can provide examples of comparable low-solubility molecules they’ve successfully formulated and scaled.
Balancing Cost With Formulation Risk
Itraconazole formulations that fail dissolution or bioequivalence testing can cost far more in delayed timelines and repeated studies than any short-term savings from choosing a lower-cost manufacturer without proven solubility-enhancement expertise. Weighing formulation risk alongside price is essential to a sound sourcing decision.
A Platform Built for Complex Molecules: Credo Life Sciences
Manufacturers such as Credo Life Sciences, a WHO-GMP certified, Hyderabad-based company incorporated in 2014, bring exactly this kind of platform capability to complex actives. Credo’s IR, SR, and EC granule technologies, combined with DMF documentation aligned to USFDA, EU, and WHO-GMP standards and a track record of bioequivalence success on demanding formulations, make it well-equipped to support the kind of rigorous formulation science that poorly soluble molecules like itraconazole require.
Conclusion: Choosing the best itraconazole granules manufacturer means prioritizing genuine solubility-enhancement expertise and regulatory documentation over price alone.